Poolbeg Pharma PLC (AIM:POLB)
London
· Delayed Price · Currency is GBP · Price in GBX 2.800
-0.050 (-1.75%)
May 13, 2025, 12:55 PM GMT+1
Poolbeg Pharma Market Cap
Poolbeg Pharma has a market cap or net worth of 14.25 million as of May 13, 2025. Its market cap has decreased by -74.55% in one year.
Market Cap
14.25M
Enterprise Value
4.19M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.80
Market Cap Chart
Since July 19, 2021, Poolbeg Pharma's market cap has decreased from 53.75M to 14.25M, a decrease of -73.49%. That is a compound annual growth rate of -29.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 14.25M | -59.86% |
| Dec 31, 2024 | 35.50M | -21.55% |
| Dec 29, 2023 | 45.25M | 49.59% |
| Dec 30, 2022 | 30.25M | -36.32% |
| Dec 31, 2021 | 47.50M | -11.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 158.79B |
| GSK plc | 55.98B |
| Haleon | 36.67B |
| Smith & Nephew | 9.35B |
| ConvaTec Group | 5.26B |
| Hikma Pharmaceuticals | 4.42B |
| HUTCHMED (China) | 1.95B |
| Genus | 1.39B |